Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

[1]  Min Jung Kim,et al.  Axillary lymph node metastasis: CA-15-3 and carcinoembryonic antigen concentrations in fine-needle aspirates for preoperative diagnosis in patients with breast cancer. , 2010, Radiology.

[2]  N. Dalay,et al.  H3K9me3/H4K20me3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer , 2010 .

[3]  P. Stieber,et al.  The Course of Circulating Nucleosomes in Liver Cancer Patients Undergoing Transarterial Chemoembolization Therapy , 2010 .

[4]  A. Spuler,et al.  Presence of Nucleosomes in Cerebrospinal Fluid of Glioblastoma Patients – Potential for Therapy Monitoring , 2010 .

[5]  O. Stoetzer,et al.  Circulating Nucleosomes and DNAse in Breast Cancer Patients During Neoadjuvant Chemotherapy , 2010 .

[6]  S. Luoh,et al.  Breast cancer in premenopausal women. , 2009, Current problems in surgery.

[7]  S. Coughlin,et al.  Breast cancer as a global health concern. , 2009, Cancer epidemiology.

[8]  R. Kimmig,et al.  Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer , 2009, Breast Cancer Research.

[9]  K. Pantel,et al.  Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer , 2009, Clinical Cancer Research.

[10]  K. Pantel,et al.  Cancer micrometastases , 2009, Nature Reviews Clinical Oncology.

[11]  K. Feldmann,et al.  Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[12]  Peter Friedl,et al.  Tube travel: the role of proteases in individual and collective cancer cell invasion. , 2008, Cancer research.

[13]  V. Heinemann,et al.  Clinical Relevance of Circulating Nucleosomes in Cancer , 2008, Annals of the New York Academy of Sciences.

[14]  D. Edwards,et al.  The regulation of matrix metalloproteinases and their inhibitors. , 2008, The international journal of biochemistry & cell biology.

[15]  Xìao-chun Xu,et al.  Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancer , 2008, International journal of cancer.

[16]  K. Pantel,et al.  A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer , 2007, Breast Cancer Research.

[17]  C. López-Otín,et al.  Emerging roles of proteases in tumour suppression , 2007, Nature Reviews Cancer.

[18]  W. Holzgreve,et al.  Levels of circulating cell-free serum DNA in benign and malignant breast lesions. , 2007, The International journal of biological markers.

[19]  M. La,et al.  HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients. , 2007 .

[20]  A. Zidan,et al.  HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients. , 2007, The Egyptian journal of immunology.

[21]  M. Fleischhacker,et al.  Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.

[22]  B. Turk.  Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[23]  N. Dalay,et al.  Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. , 2006, Experimental and molecular pathology.

[24]  D. Pisetsky,et al.  The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells , 2005, Immunology.

[25]  D. Pisetsky,et al.  The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum , 2005, Journal of leukocyte biology.

[26]  K. Pantel,et al.  Detection and Characterization of Circulating Microsatellite‐DNA in Blood of Patients with Breast Cancer , 2004, Annals of the New York Academy of Sciences.

[27]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[28]  W. Doerfler,et al.  Ingested foreign (phage M13) DNA survives transiently in the gastrointestinal tract and enters the bloodstream of mice , 1994, Molecular and General Genetics MGG.

[29]  N. Brünner,et al.  Comparative evaluation of urokinase‐type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells , 2003, International journal of cancer.

[30]  D. Gotley,et al.  Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis , 2003, Thrombosis and Haemostasis.

[31]  M. Stroun,et al.  About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[32]  M. Toi,et al.  Clinical significance of plasma nucleosome levels in cancer patients. , 2001, International journal of oncology.

[33]  M. Toi,et al.  Plasma nucleosome levels in node-negative breast cancer patients , 1999, Breast cancer.

[34]  Y. Soini,et al.  Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion , 1999, British Journal of Cancer.

[35]  Y. Soini,et al.  Histopathological evaluation of apoptosis in cancer. , 1998, The American journal of pathology.

[36]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[37]  C. Steinman,et al.  Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome‐like structure and clearance , 1992, Clinical and experimental immunology.